PATENT CLAIM ANALYSIS

Application Number: 15910783
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "243100"]

Abstract:
The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of  Staphylococcus aureus . One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from  S. aureus  and an antigenic material from a  S. aureus -specific polypeptide.

Claim (Index 29):
The chimeric protein of  claim 23 , wherein the chimeric protein is assembled from a first polypeptide and a second polypeptide that are non-covalently linked.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 2.01923
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14456090', '13896854', '11988598', '15102125', '12603211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7577930121311517
- 35 USC 102 Novelty (BERT): 0.5570223002876453
- Combined Prediction Score: 0.737715940946801
- Mean Citation Score: 329.7317060000001
- Max Citation Score: 460.43018
- Similarity Product: 304.9073093316281

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test